These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6130957)

  • 1. In vitro studies with (imidazolinyl-2)-2-benzodioxane-1-4 ((+/-)-170 150), a new potent alpha 2-adrenoceptor blocking agent.
    Dabiré H; Dausse JP; Mouillé P; Schmitt H; Meyer P
    Eur J Pharmacol; 1982 Dec; 86(1):87-90. PubMed ID: 6130957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
    Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
    Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC; Roach AG; Smith CF
    Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
    Doxey JC; Lane AC; Roach AG; Virdee NK
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonists interaction with radiolabeled alpha-adrenoceptor antagonists binding sites in rat mesenteric artery.
    Agrawal DK; Daniel EE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S66-75. PubMed ID: 2414598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
    Gadie B; Lane AC; McCarthy PS; Tulloch IF; Walter DS
    Br J Pharmacol; 1984 Nov; 83(3):707-12. PubMed ID: 6150739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: competition studies with [3H]prazosin and [3H]idazoxan.
    Reader TA; Brière R; Grondin L
    J Neural Transm; 1987; 68(1-2):79-95. PubMed ID: 2879884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of stereoisomers of (imidazolinyl-2)-2-benzodioxane-1-4 or 2-(2-(1,4-benzodioxanyl))-2-imidazoline (170 150; RX 781094) on peripheral presynaptic and central alpha 2-adrenoceptors.
    Dabiré H; Mouillé P; Schmitt H
    Eur J Pharmacol; 1982 Dec; 86(1):83-6. PubMed ID: 6297928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
    Perrone MH; Hamel LT; Ferrari RA; Haubrich DR
    J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on YM-12617: a selective and potent antagonist of postsynaptic alpha 1-adrenoceptors.
    Honda K; Takenaka T; Miyata-Osawa A; Terai M; Shiono K
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):264-72. PubMed ID: 2858821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (Imidazolinyl-2)-2-benzodioxane 1-4 (idazoxan) and its stereoisomers, new alpha 2-antagonists.
    Dabiré H; Mouille P; Schmitt H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S127-9. PubMed ID: 2414573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonist/agonist-preferring alpha-adrenoceptors or alpha 1/alpha 2-adrenoceptors?
    Tanaka T; Starke K
    Eur J Pharmacol; 1980 May; 63(2-3):191-4. PubMed ID: 6103816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]clonidine and [3H]WB4101 to the pre- and postsynaptic alpha-adrenoceptors of the basal hypothalamus of the starved male rat.
    Spyra B; Pirke KM
    Brain Res; 1982 Aug; 245(1):179-82. PubMed ID: 6126263
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens.
    Hicks PE; Langer SZ; Macrae AD
    Br J Pharmacol; 1985 Sep; 86(1):141-50. PubMed ID: 2864967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding characteristics of [3H]guanfacine to rat brain alpha-adrenoceptors. Comparison with [3H]clonidine.
    Timmermans PB; Schoop AM; van Zwieten PA
    Biochem Pharmacol; 1982 Mar; 31(6):899-905. PubMed ID: 6282284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
    Hanft G; Gross G
    Br J Pharmacol; 1989 Jul; 97(3):691-700. PubMed ID: 2569345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.